Skip to main content
Log in

Neuroimaging of aggressive pituitary tumors

  • Published:
Reviews in Endocrine and Metabolic Disorders Aims and scope Submit manuscript

Abstract

Aggresssive pituitary tumors are defined as radiologically invasive, exhibiting a rapid growth and a poor response to the medical and surgical treatment options. The role of magnetic resonance imaging (MRI) is fundamental to assess tumor aggressiveness before surgical exploration. Distinction between cavernous sinus invasion and cavernous sinus compression is often challenging and cannot be solved always by using the Knosp criteria. Ideally, T2W images demonstrating the ruptured internal dural wall of cavernous sinus is the ultimate proof of cavernous sinus invasion. Subtle tumor volume increase in a short time can be shown when sequential MR images are rigorously replicable. A microcystic pattern observed on T2W images frequently reflects a potentially aggressive tumor as observed in silent corticotroph pituitary adenomas.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9
Fig. 10
Fig. 11
Fig. 12

Similar content being viewed by others

References

  1. Chatzellis E, Alexandraki KI, Androulakis II, Kaltsas G Aggressive pituitary tumors, Neuroendocrinology. 2015;101(2):87–104. https://doi.org/10.1159/000371806 Epub 2015 Jan 5 Review.

  2. Lasolle H, Ilie MD, Raverot G. Aggressive prolactinomas: how to manage? Pituitary. 2020 Feb;23(1):70–7. https://doi.org/10.1007/s11102-019-01000-7 Review.

  3. Bonneville JF. Magnetic resonance imaging of pituitary tumors. Front Horm Res 2016;45:97–120. https://doi.org/10.1159/000442327. Epub 2016 Mar 15.

  4. Cottier JP, Destrieux C, Brunereau L, Bertrand P, Moreau L, Jan M, et al. Cavernous sinus invasion by pituitary adenoma: MR imaging. Radiology. 2000;215(2):463–9.

    Article  CAS  Google Scholar 

  5. Sol YL , Lee SK, Choi HS, Lee YH, Kim J, Kim SH. Evaluation of MRI criteria for cavernous sinus invasion in pituitary macroadenoma J Neuroimaging. 2014 Sep-Oct;24(5):498–503. https://doi.org/10.1111/j.1552-6569.2012.00710.x. Epub 2012 Nov 15.

  6. Bonneville JF, Cattin F, Racle A, Bouchareb M, Boulard D, Potelon P, et al. Dynamic CT of the laterosellar extradural venous spaces. AJNR Am J Neuroradiol. 1989 May-Jun;10(3):535–42.

  7. Knosp E, Steiner E, Kitz K, Matula C. Pituitary adenomas with invasion of the cavernous sinus space: a magnetic resonance imaging classification compared with surgical findings. Neurosurgery. 1993;33:610–7.

    CAS  PubMed  Google Scholar 

  8. Micko ASG, Wöhrer A, Wolfsberger S, Knosp E. Invasion of the cavernous sinus space in pituitary adenomas: endoscopic verification and its correlation with an MRI-based classification. Neurosurg. 2015;122:803–11.

    Article  Google Scholar 

  9. Xu XY, Wang RZ, Zhi ZYXZ. Performance of Knosp grade for cavernous sinus invasion of Cushing's disease. Chinese. 2019 Jan 29;99(5):388–90. https://doi.org/10.3760/cma.j.issn.0376-2491.2019.05.014.

  10. Cao L, Chen H, Hong J, Ma M, Zhong Q, Wang S. Magnetic resonance imaging appearance of the medial wall of the cavernous sinus. J Neuroradiol. 2013;40:245–51.

    Article  Google Scholar 

  11. Mooney MA, Hardesty DA, Sheehy JP, Bird R, Chapple K, White WL, et al. Interrater and intrarater reliability of the Knosp scale for pituitary adenoma grading. J Neurosurg. 2017 May;126(5):1714–9. https://doi.org/10.3171/2016.3.JNS153044.

    Article  PubMed  Google Scholar 

  12. Bonneville JF, Bonneville F, Cattin F, Nagi S, editors. Cavernous sinus invasion in MRI of the pituitary gland. Berlin, Germany: Springer; 2016. p. 77–83.

    Google Scholar 

  13. Bonneville JF. A plea for the T2W MR sequence for pituitary imaging. Pituitary. 2019 Apr;22(2):195–7. https://doi.org/10.1007/s11102-018-0928-9.

    Article  PubMed  Google Scholar 

  14. Potorac I, Beckers A, Bonneville JF. T2-weighted MRI signal intensity as a predictor of hormonal and tumoral responses to somatostatin receptor ligands in acromegaly: a perspective. Pituitary. 2017 Feb;20(1):116–20. https://doi.org/10.1007/s11102-017-0788-8.

    Article  CAS  PubMed  Google Scholar 

  15. Balogun JA, Monsalves E, Juraschka K, Parvez K, Kucharczyk W, Mete O, et al. Null cell adenomas of the pituitary gland: an institutional review of their clinical imaging and behavioral characteristics. Endocr Pathol. 2015;26(1):63–70. https://doi.org/10.1007/s12022-014-9347-2 CrossRefPubMedGoogle Scholar 1.64.

  16. Brochier S, Galland F, Kujas M, Parker F, Gaillard S, Raftopoulos C, et al. Factors predicting relapse of nonfunctioning pituitary macroadenomas afterneurosurgery: a study of 142 patients. Eur J Endocrinol. 2010;163(2):193–200. https://doi.org/10.1530/eje-10-0255.

    Article  CAS  PubMed  Google Scholar 

  17. Drummond J, Roncaroli F, Grossman A B , Korbonits M. Clinical and pathological aspects of silent pituitary adenomas. J Clin Endocrinol Metab. 2019 Jul; 104(7): 2473–2489. Published online 2018 Jul 17. https://doi.org/10.1210/jc.2018-00688.

  18. Ben-Shlomo A, Cooper O. Silent corticotroph adenomas. Pituitary. 2018;21(2):183–93.

    Article  CAS  Google Scholar 

  19. Cazabat L, Dupuy M, Boulin A, Bernier M, Baussart B, Foubert L, et al. Silent, but not unseen: multimicrocystic aspect on T2-weighted MRI in silent corticotroph adenomas. Clin Endocrinol. 2014;81(4):566–72.

    Article  CAS  Google Scholar 

  20. Kaltsas GA, Nomikos P, Kontogeorgos G, Buchfelder M, Grossman AB. Clinical review: diagnosis and management of pituitary carcinomas. J Clin Endocrinol Metab. 2005;90:3089–99.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to J. F. Bonneville.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bonneville, J.F., Potorac, J. & Beckers, A. Neuroimaging of aggressive pituitary tumors. Rev Endocr Metab Disord 21, 235–242 (2020). https://doi.org/10.1007/s11154-020-09557-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11154-020-09557-6

Keywords

Navigation